Sebaceous carcinoma of lacrimal gland with endophthalmitis


  • Dinar Aulia Department of Ophthalmology, Dr. Ramelan Navy Hospital, Surabaya, East Java, Indonesia
  • Empi Irawan Department of Ophthalmology, Dr. Ramelan Navy Hospital, Surabaya, East Java, Indonesia



Sebaceous carcinoma, Tumor, Lacrimal gland


Sebaceous carcinoma (SC) is a rare type of cancer that aggressive which develops from the sebaceous glands and can impair patients’ visual acuity. It usually arises from the periorbital area, which commonly affects in the eyelid. This study discusses the sebaceous carcinoma of lacrimal gland with endophthalmitis. The patient was a 53-year-old Javanese man came with a chief complaint of no vision in his left eye, painlessness nowadays, no previous medical history, and slowly progressive swelling mass on the outer aspect of the left upper eyelid for a year duration. On examination, there was no light perception for the left eye and 6/7, 5 on the right eye. The tumor was rock hard and fixed on palpation, which caused partial upper eyelid ptosis, displaced the globe anteromedially, and impaired ocular motility. There was also a massive chemosis in the left eye, ptosis with corneal damage caused by endophthalmitis. The histopathological examination found that the tumor was composed of nests of cuboidal and columnar cells with proliferation round core cells, pleomorphic, hyperchromatic, vacuole cytoplasm, and prominent nuclei, arranged in a solid structure without lymphovascular invaded. The final diagnosis was sebaceous carcinoma of the lacrimal gland. The patient took tumor excision surgery followed by orbital evisceration due to endophthalmitis with post-operative radiotherapy as an alternative treatment. Sebaceous carcinoma of the lacrimal gland is extremely rare. There are no specific treatments, and it is difficult to study further for the best treatment due to its rare incidence. Sebaceous carcinoma of the lacrimal gland has so far been treated best by surgical excision and radiotherapy after.


Clair Mallen-St J, Arshi A, Tajudeen B, Abenmayor E, John MS. Epidemiology and treatment of lacrimal gland tumor a population-based cohort analysis. Jama Otolaryngol Head Neck Surg. 2014;140(12):110-6.

See TR, Stalhammar G, Tang T, Manusow J, Jordan D, Nerad J, et al. Primary ductal adenocarcinoma of the lacrimal gland: A review and report of five cases. Survey Ophtahlmol Elsevier J. 2020;65(3):371-80.

Park H, Choi Gyu S. Primary sebaceous carcinoma of lacrimal gland: A case report and review of literature. World J Clin Cases. 2018;6(16):1194-8.

Xu Y, Li F, Jia R, Fan X. Updates on the clinical diagnosis and management of ocular sebaceous carcinoma: a brief review of the literature. Dovepress. 2018;11:3713-5.

Cheung JJC, Esmaeli B, Lam SC, Kwok T, Yuen HKL. The practice patterns in the management of sebaceous carcinoma of the eyelid in the Asia Pacific region. Royal Coll Ophthalmol. 2019;33:1433-40.

Dores GM, Curtis RE, Toro JR, Devesa SS, Fraumeni JF. Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms: insight into Muir-Torre syndrome. Cancer. 2008;15;113(12):3372-81.

Shields JA, Saktanasate J, Lally SE, Carrasco JR, Shields CL. Sebaceous carcinoma of the oculare region: the Professor Winifred Mao Lecture. Asia-Pacific J Ophthalmol. 2015;4(4):221-5.

Kuzel P, Metelitsa AI, Dover DC, Salopek TG. Epidemiology of sebaceous carcinoma in Alberta, Canada, from 1988 to 2007. J Cutan Med Surg. 2012;16(6):417-23.

Granada CP, Waitkus PR. Sebaceous carcinoma of the eyelid. SAGE Journals. 2016;23(2):126-25.

Lima CG, Chahud F, Paiva CJ, Nebl D, Cruz AA. Primary adenocarcinoma of the lacrimal gland with sebaceous differentiation in a 4-year-old child. Ophthalmic Plast Reconstr Surg. 2014;30(3):55-7.

Salazar-Villegas Á, Matas J, Palma-Carvajal F, González-Valdivia H, Alos L, Ortiz-Pérez S. Sebaceous carcinoma of the caruncle. J Fr Ophtalmol. 2019;42(8):925-7.

Rajan Kd A, Burris C, Iliff N, Grant M, Eshleman JR, Eberhart CG. DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma. Am J Ophthalmol. 2014;157(3):640-7.

Shields JA, Shields CL, Epstein JA, Scartozzi R, Eagle RC Jr. Review: primary epithelial malignancies of the lacrimal gland: the 2003 Ramon L. Font lecture. Ophthalmic Plast Reconstr Surg. 2004;20(1):10-2.

Gall R, Ortiz-Perez S. Sebaceous Gland Carcinoma. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2022.

Muqit MM, Foot B, Walters SJ, Mudhar HS, Roberts F, Rennie IG. Observational prospective cohort study of patients with newly-diagnosed ocular sebaceous carcinoma. Br J Ophthalmol. 2013;97(1):47-51.

Andreasen S, Esmaeli B, von Holstein SL, Mikkelsen LH, Rasmussen PK, heegard S. An update on tumors of the lacrimal gland. Asia-Pacific Acad Ophtahlmol. 2017;6(2):165-6.

Merly ANL, Toledo LA, Requejo GA, Meléndez A, Álvarez S, López A, Ríos R, Oliver V. Risk factors leading to enucleation or evisceration in infectious endophtahlmitis. J Clin Med. 2022;11:5-7.

Sa HS, Rubin ML, Xu S, Ning J, Tetzlaff M, Sagiv O, Kandl TJ, Esmaeli B. Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients. Br J Ophtahlmol. 2019;103:980-4.

Yoon JS, Kim SH, Lee CS, Lew H, Lee SY. Clinicopathological analysis of periocular sebaceous gland carcinoma. Ophthalmologica. 2007;221:331-9.

Park SK, Park J, Kim HU, Yun SK. Sebcaeous carcinoma: clincopathologic analysis of 29 cases a tertiary hospital in Korea. Korean Assoc Med J Editors. 2017;32:1357-8.




How to Cite

Aulia, D., & Irawan, E. (2022). Sebaceous carcinoma of lacrimal gland with endophthalmitis. International Journal of Research in Medical Sciences, 10(12), 2936–2940.



Case Reports